Proof-of-Concept Trial for X-Linked Chronic Granulomatous Disease Treatment Shows Promise

According to a story from Markets Insider, the biopharmaceutical company Orchard Therapeutics recently announced the presentation of proof-of-concept data in regards to their investigational drug candidate OTL-102. This experimental therapy…

Continue Reading Proof-of-Concept Trial for X-Linked Chronic Granulomatous Disease Treatment Shows Promise

International Genetic Research Group to Begin Study of Hypermobile Ehlers-Danlos Syndrome (hEDS)

A recent announcement by the Ehlers-Danlos Society marks the beginning of the recruitment phase for an international study devoted to determining the root cause of hEDS. The gathering of this…

Continue Reading International Genetic Research Group to Begin Study of Hypermobile Ehlers-Danlos Syndrome (hEDS)
Bioscience Companies in Ohio Take Aim at Rare Diseases
source: pixabay.com

Bioscience Companies in Ohio Take Aim at Rare Diseases

According to a story from BioPortfolio, Rare Disease Day, which took place on February 28th, 2019, serves as a time of reflection on the progress that has been made in…

Continue Reading Bioscience Companies in Ohio Take Aim at Rare Diseases
A Beta Thalassemia Patient will be the First Dosed with CRISPR-Based Gene Therapy in Company Sponsored Trial
mcmurryjulie / Pixabay

A Beta Thalassemia Patient will be the First Dosed with CRISPR-Based Gene Therapy in Company Sponsored Trial

According to a story from MedCity News, a patient with the rare blood disorder beta thalassemia will be the first patient dosed in a Phase I/II clinical trial involving a…

Continue Reading A Beta Thalassemia Patient will be the First Dosed with CRISPR-Based Gene Therapy in Company Sponsored Trial

Study Investigates the Most Predictive Indicators of Bronchopulmonary Dysplasia

What is Bronchopulmonary Dysplasia? Bronchopulmonary Dysplasia (BPD) is a diagnosis most commonly given to premature newborns. In children, BPD is also the most common cause of Pulmonary Hypertension (PH). Premature babies often develop…

Continue Reading Study Investigates the Most Predictive Indicators of Bronchopulmonary Dysplasia

Updates From Celgene in Follicular Lymphoma, Marginal Zone Lymphoma, Beta Thalassemia, and other Rare Diseases

Celgene Corporation has recently announced two exciting updates for the rare disease community! Update #1 The first big announcement from Celgene was that their supplemental New Drug Application (sNDA) for…

Continue Reading Updates From Celgene in Follicular Lymphoma, Marginal Zone Lymphoma, Beta Thalassemia, and other Rare Diseases

First Potential Gene Therapy for Tay-Sachs Disease Produces Positive Results at Three Month Mark

Tay-Sachs disease is a rare, genetic and sadly fatal condition. It's a neurodegenerative disorder caused by an impaired production of the β-Hexosaminidase A enzyme (HEXA). Symptoms of this condition include listlessness, diminishing…

Continue Reading First Potential Gene Therapy for Tay-Sachs Disease Produces Positive Results at Three Month Mark
Phase 2 Clinical Trial for Pulmonary Hypertension has Officially Begun
source: pixabay.com

Phase 2 Clinical Trial for Pulmonary Hypertension has Officially Begun

About Pulmonary Hypertension Pulmonary Hypertension (PH) is a form of high blood pressure which affects the arteries. Primary Pulmonary Hypertension refers to a type of the condition whose origin is unknown. Secondary…

Continue Reading Phase 2 Clinical Trial for Pulmonary Hypertension has Officially Begun

Positive Results from Phase 2 Trial Could Lead to Lower Doses of Corticosteroids for Pemphigus Patients

Pemphigus Pemphigus is a rare autoimmune condition which causes the skin to blister. There are two main forms of the disease called pemphigus foliaceus (PF) and pemphigus vulgaris (PV). Pemphigus…

Continue Reading Positive Results from Phase 2 Trial Could Lead to Lower Doses of Corticosteroids for Pemphigus Patients
Study Shows We Need Better Awareness of Pediatric Onset Multiple Sclerosis to Improve Patient Care
source: pixabay.com

Study Shows We Need Better Awareness of Pediatric Onset Multiple Sclerosis to Improve Patient Care

Multiple Sclerosis (MS) was long believed to be an illness that could only affect adults. In fact, the pediatric form of this disease was not discovered until just over 10…

Continue Reading Study Shows We Need Better Awareness of Pediatric Onset Multiple Sclerosis to Improve Patient Care

Study has Commenced for a New Potential Familial Chylomicronemia Syndrome Treatment

Hypertriglyceridemia Hypertriglyceridemia is the term used to describe abnormally high numbers of triglycerides in the blood. People with Hypertriglyceridemia have an increased risk of heart disease, stroke, and heart attack.…

Continue Reading Study has Commenced for a New Potential Familial Chylomicronemia Syndrome Treatment

Results From the Longest Familial Hypercholesterolemia Study to be Announced at the ACC 2019 Conference

New Research to be Presented In just a few days the American College of Cardiology will host their 68th Annual Scientific Session (ACC.19). It will be held in New Orleans,…

Continue Reading Results From the Longest Familial Hypercholesterolemia Study to be Announced at the ACC 2019 Conference

The Argument for Mandatory Newborn Screening and Government Subsidies for Rare Diseases in India

The State of Rare Disease in India There are 7,000 known rare diseases worldwide. The Organization for Rare Diseases India (ORDI) estimates 70 million people are affected by a rare diagnosis…

Continue Reading The Argument for Mandatory Newborn Screening and Government Subsidies for Rare Diseases in India

New Potential Treatment for Systemic-Onset Juvenile Idiopathic Arthritis Investigated in China

SOJIA SOJIA stands for systemic-onset Juvenile Idiopathic Arthritis (JIV). It is a very severe form of JIA which causes joint pain, inflammation, recurrent fevers, and a skin rash. Patients often take predinsolone,…

Continue Reading New Potential Treatment for Systemic-Onset Juvenile Idiopathic Arthritis Investigated in China